Summary Congenital musculoskeletal defects caused 11 200 deaths (95% UI 8020–15 900) in 2019 among all ages. 17·7 million (13·6–22·2) people were living with congenital musculoskeletal and limb anomalies in 2019, a 24·8% (21·2–29·3) increase since 1990.
Definition Congenital musculoskeletal defects is an anomaly of the muscles or skeletal system present at birth that is not caused by a defined chromosomal syndrome. We explicitly model three sub-categories: polydactyly and syndactyly, limb reduction defects, and all other congenital musculoskeletal anomalies.
Total sources | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Incidence | 0 | |||||||||||
Prevalence | 1635 | |||||||||||
Remission | 0 | |||||||||||
Causes of death | 2584 | |||||||||||
Other | 4 | |||||||||||
Table 1:
Total sources used in GBD 2019 estimation
What is new in GBD 2019?
- •We revised data processing to include age-sex splitting using location-year-specific empirical age-sex patterns which improved how COD results informed prevalence and incidence models.
- •We performed data adjustments for alternate definitions (alternates included when stillbirths or terminations included, chromosomal anomalies excluded, or datum included only a subset of defects) using MR-BRT prior to modelling.
- •We revised clinical administrative data processing to better account for inpatient:outpatient visits.
- •We revised DisMod-MR 2.1 covariates to match those that were most predictive in CODEm.
- •We revised model settings to better account for possibility of remission in all of our congenital musculoskeletal models.
Prevalence
|
Incidence
|
Deaths
|
YLLs
|
YLDs
|
DALYs
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cases
(millions) |
Rate (per 100 000)
|
Cases
(millions) |
Rate (per 100 000)
|
Deaths
(millions) |
Rate (per 100 000)
|
YLLs
(millions) |
Rate (per 100 000)
|
YLDs
(millions) |
Rate (per 100 000)
|
DALYs
(millions) |
Rate (per 100 000)
|
|
2019 | ||||||||||||
Both Sexes | 17·7 (13·6 to 22·2) |
238·9 (182·5 to 299·6) |
2·30 (1·46 to 3·20) |
35·5 (22·5 to 49·4) |
0·0112 (0·00802 to 0·0159) |
0·2 (0·1 to 0·2) |
0·941 (0·666 to 1·36) |
14·2 (10·0 to 20·7) |
2·58 (1·63 to 3·79) |
34·8 (22·0 to 51·3) |
3·52 (2·51 to 4·75) |
49·1 (34·8 to 66·0) |
Females | 9·06 (7·05 to 11·3) |
247·8 (191·1 to 309·6) |
1·12 (0·712 to 1·56) |
35·9 (22·8 to 50·0) |
0·00488 (0·00306 to 0·00762) |
0·2 (0·1 to 0·2) |
0·409 (0·253 to 0·646) |
12·8 (7·9 to 20·3) |
1·32 (0·834 to 1·94) |
36·2 (23·0 to 52·8) |
1·73 (1·19 to 2·34) |
48·9 (33·6 to 66·4) |
Males | 8·63 (6·58 to 10·8) |
230·1 (174·8 to 289·3) |
1·18 (0·741 to 1·64) |
35·1 (22·1 to 48·9) |
0·00629 (0·00440 to 0·00930) |
0·2 (0·1 to 0·3) |
0·532 (0·368 to 0·798) |
15·6 (10·8 to 23·5) |
1·26 (0·794 to 1·87) |
33·5 (21·1 to 49·5) |
1·79 (1·26 to 2·42) |
49·2 (34·5 to 66·5) |
Percentage change 2010-19 | ||||||||||||
Both Sexes | 7·7% (6·4 to 8·9) |
0·2% (–0·9 to 1·3) |
–1·1% (–3·4 to 0·9) |
0·2% (–2·2 to 2·2) |
–12·1% (–26·7 to 5·6) |
–12·6% (–27·1 to 5·1) |
–12·7% (–27·4 to 5·6) |
–12·7% (–27·4 to 5·8) |
7·6% (6·1 to 9·0) |
0·2% (–1·2 to 1·5) |
1·3% (–6·8 to 7·0) |
–3·9% (–11·3 to 1·7) |
Females | 7·8% (6·3 to 9·1) |
0·0% (–1·5 to 1·2) |
–0·7% (–3·3 to 1·7) |
0·5% (–2·1 to 3·0) |
–11·9% (–28·4 to 8·7) |
–12·7% (–29·1 to 7·8) |
–12·7% (–29·2 to 8·6) |
–12·9% (–29·4 to 8·5) |
7·6% (5·9 to 9·2) |
0·0% (–1·9 to 1·5) |
2·0% (–6·9 to 7·8) |
–3·7% (–12·0 to 2·0) |
Males | 7·5% (6·0 to 9·2) |
0·5% (–0·8 to 1·8) |
–1·5% (–4·0 to 0·9) |
–0·1% (–2·7 to 2·3) |
–12·2% (–27·5 to 5·8) |
–12·6% (–27·6 to 5·6) |
–12·7% (–27·9 to 5·7) |
–12·6% (–27·8 to 6·0) |
7·5% (5·6 to 9·3) |
0·5% (–1·2 to 2·1) |
0·6% (–8·7 to 7·1) |
–4·1% (–13·0 to 2·3) |
Numbers in parentheses are 95% uncertainty intervals. |
Table 2:
Global prevalence, incidence, deaths, YLLs, YLDs, and DALYs in counts and age-standardised rates for both sexes combined, females, and males, 2019, with percentage change between 2010 and 2019
Deaths | YLLs | YLDs | DALYs | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1990 | 171st | 139th | 65th | 120th | ||||||||
2010 | 173rd | 143rd | 69th | 130th | ||||||||
2019 | 174th | 149th | 70th | 131st | ||||||||
Table 3:
Rank among most detailed causes for global deaths, YLLs, YLDs, and DALYs in 1990, 2010, and 2019, for both sexes combined

Figure 1:
Composition of DALYs by YLLs and constituent sequelae YLDs for both sexes combined, 2019


Figure 2:
Age-standardised DALY rates for each location by SDI, both sexes combined, 2019

Figure 3:
Composition of DALYs by YLLs and YLDs, age group, and sex, 2019


Figure 4:
Age-standardised DALY rates (per 100 000) by location, both sexes combined, 2019